List of SBIR/STTR awards granted to MTI Biotech Incorporated
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A STTR Phase I contract was awarded to MTI Biotech Incorporated in April, 2021 for $400,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41CA257262-01A1 | Phase I | 400,000 | April 9, 2021 | |||||||
A STTR Phase I contract was awarded to MTI Biotech Incorporated in August, 2021 for $256,580.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41HL158393-01 | Phase I | 256,580 | August 1, 2021 | |||||||
A SBIR Phase II contract was awarded to MTI Biotech Incorporated in September, 2016 for $1,506,752.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AG055184-01 | Phase II | 1,506,752 | September 30, 2016 | |||||||
A SBIR Phase II contract was awarded to MTI Biotech Incorporated in March, 2014 for $847,743.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44AG034722-02 | Phase II | 847,743 | March 15, 2014 | |||||||
A SBIR Phase I contract was awarded to MTI Biotech Incorporated in January, 2013 for $150,000.0 USD from the National Science Foundation. | SBIR | 1248803 | Phase I | 150,000 | January 1, 2013 | |||||||
A SBIR Phase II contract was awarded to MTI Biotech Incorporated for $743,098.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44AG020897-02 | Phase II | 743,098 | ||||||||
A SBIR Phase I contract was awarded to MTI Biotech Incorporated for $99,990.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43DK061818-01A1 | Phase I | 99,990 | ||||||||
A SBIR Phase I contract was awarded to MTI Biotech Incorporated for $151,587.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AA023715-01 | Phase I | 151,587 | ||||||||
A SBIR Phase I contract was awarded to MTI Biotech Incorporated for $100,001.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AG020897-01A1 | Phase I | 100,001 | ||||||||
A SBIR Phase I contract was awarded to MTI Biotech Incorporated for $100,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AG034722-01A1 | Phase I | 100,000 | ||||||||
A SBIR Phase I contract was awarded to MTI Biotech Incorporated from the U.S. Department of Health & Human Services. | SBIR | Phase I | 0 | |||||||||
A SBIR Phase II contract was awarded to MTI Biotech Incorporated for $386,951.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase II | 386,951 | |||||||||
A SBIR Phase I contract was awarded to MTI Biotech Incorporated for $80,000.0 USD from the U.S. Department of Agriculture. | SBIR | 2005-33610-15631 | Phase I | 80,000 | ||||||||
A SBIR Phase I contract was awarded to MTI Biotech Incorporated for $98,900.0 USD from the U.S. Department of Health & Human Services. | SBIR | Phase I | 98,900 | |||||||||
A STTR Phase II contract was awarded to MTI Biotech Incorporated in September, 2023 for $1,173,060.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 2R42HL158393-02 | Phase II | 1,173,060 | September 1, 2023 |
